Patents by Inventor F. Jon Kull

F. Jon Kull has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection
    Patent number: 10377716
    Abstract: Bicyclic compounds for decreasing the expression of bacterial virulence factors thereby preventing, mitigating, or treating bacterial infection are provided.
    Type: Grant
    Filed: October 16, 2017
    Date of Patent: August 13, 2019
    Assignee: TRUSTEES OF DARTMOUTH COLLEGE
    Inventors: F. Jon Kull, Ronald K. Taylor, Gordon W. Gribble, Evans O. Onyango, Anne R. Kelley
  • COMPOSITION AND METHOD FOR PREVENTION, MITIGATION OR TREATMENT OF AN ENTEROPATHOGENIC BACTERIAL INFECTION
    Publication number: 20180029990
    Abstract: Bicyclic compounds for decreasing the expression of bacterial virulence factors thereby preventing, mitigating, or treating bacterial infection are provided.
    Type: Application
    Filed: October 16, 2017
    Publication date: February 1, 2018
    Inventors: F. Jon Kull, Ronald K. Taylor, Gordon W. Gribble, Evans O. Onyango, Anne R. Kelley
  • Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection
    Patent number: 9790186
    Abstract: Bicyclic compounds for decreasing the expression of bacterial virulence factors thereby preventing, mitigating, or treating bacterial infection are provided.
    Type: Grant
    Filed: August 27, 2015
    Date of Patent: October 17, 2017
    Assignee: TRUSTEES OF DARTMOUTH COLLEGE
    Inventors: F. Jon Kull, Ronald K. Taylor, Gordon W. Gribble, Evans O. Onyango, Anne R. Kelley
  • COMPOSITION AND METHOD FOR PREVENTION, MITIGATION OR TREATMENT OF AN ENTEROPATHOGENIC BACTERIAL INFECTION
    Publication number: 20150361045
    Abstract: Bicyclic compounds for decreasing the expression of bacterial virulence factors thereby preventing, mitigating, or treating bacterial infection are provided.
    Type: Application
    Filed: August 27, 2015
    Publication date: December 17, 2015
    Applicant: Trustees of Dartmouth College
    Inventors: F. Jon Kull, Ronald K. Taylor, Gordon W. Gribble, Evans O. Onyango, Anne R. Kelley
  • Hybrid prokaryotic-eukaryotic tubulins and use thereof
    Patent number: 8741307
    Abstract: The present invention embraces hybrid Prosthecobacter-eukaryotic tubulin proteins and use thereof for identifying agents that modulate the activity of tubulin.
    Type: Grant
    Filed: April 19, 2010
    Date of Patent: June 3, 2014
    Assignee: Trustees of Dartmouth College
    Inventors: F. Jon Kull, Jared C. Cochran
  • Composition and Method for Prevention, Mitigation or Treatment of an Enteropathogenic Bacterial Infection
    Publication number: 20120157529
    Abstract: The present invention embraces the use of palmitoleic acid, or a derivative, mimetic, or extract containing the same, to decrease the expression of bacterial virulence factors thereby preventing, mitigating, or treating bacterial infection.
    Type: Application
    Filed: July 21, 2010
    Publication date: June 21, 2012
    Applicant: Trustees of Dartmouth College
    Inventors: F. Jon Kull, Ronald K. Taylor, Michael Lowden, Karen Skorupski, Jessica Day, Gabriela Kovacikova
  • Hybrid Prokaryotic-Eukaryotic Tubulins and Use Thereof
    Publication number: 20120045785
    Abstract: The present invention embraces hybrid Prosthecobacter-eukaryotic tubulin proteins and use thereof for identifying agents that modulate the activity of tubulin.
    Type: Application
    Filed: April 19, 2010
    Publication date: February 23, 2012
    Inventors: F. Jon Kull, Jared C. Cochran